Roundup and analysis of the top headlines on health security, pandemic preparedness, COVID-19, and other news from the Johns Hopkins Center for Health Security


Please note that some links may require subscription or registration.

August 15, 2024



TOP NEWS

WHO, Africa CDC declare mpox outbreak as international, continental emergencies to mobilize more robust, equitable international response

For the second time in 2 years, WHO Director-General Dr. Tedros Adhanom Ghebreyesus on August 14 declared mpox a public health emergency of international concern (PHEIC) under the International Health Regulations (2005) (IHR), this time in response to a growing outbreak in Africa. The designation comes on the advice of an IHR emergency committee, which met earlier in the day. In making the declaration, Dr. Tedros noted the emergence of a new clade I variant of mpox, clade Ib, and its rapid spread in eastern Democratic Republic of Congo (DRC) and into several neighboring countries, additional outbreaks of other mpox clades in DRC and other countries in Africa, and the potential for mpox to spread further in Africa and beyond. Notably, Sweden today confirmed a case of the new clade Ib virus in a person who had traveled to Africa, confirming that the threat of spread beyond Africa’s borders is likely.


The WHO move follows a similar declaration made by the Africa CDC on August 13, officially naming the mpox outbreak a public health emergency of continental security (PHECS), marking the first time the agency has made such a declaration since its inception in 2017. So far this year, at least 12 African countries—including previously unaffected nations like Burundi, Kenya, Rwanda, and Uganda—have reported mpox outbreaks, with 2,863 confirmed cases and 517 deaths, according to Africa CDC. Suspected cases across Africa have surged to more than 17,000 so far this year, a significant increase from the 14,957 cases reported in all of 2023. Mpox was first detected in humans in DRC in 1970 and is endemic in parts of the African continent.


What are the different clades of mpox virus?

The mpox virus has 2 main clades: clade I and clade II. Clade I, which is endemic to Central Africa, is more virulent, with higher mortality rates. Clade II, endemic to West Africa, is less severe and includes subclades IIa and IIb. Clade IIb was responsible for the 2022 global outbreak that led to nearly 100,000 confirmed cases, including 208 deaths, and that primarily affected men who have sex with men. The new clade Ib variant that recently emerged in DRC has spread rapidly, affected a broader population, including a large proportion of children, and has shown higher transmissibility and severity than clade IIb infections.


What is the significance of the PHEIC and PHECS declarations?

The declarations are meant to mobilize international resources, enhance collaboration, and accelerate research to control the mpox outbreaks. They provide a framework for countries to implement necessary public health measures and improve acquisition and distribution of medical countermeasures such as vaccines, treatments, and diagnostics, as well as personal protective equipment and disinfectants.


Why and when did WHO end the previous mpox PHEIC?

The previous mpox PHEIC, declared in July 2022, was ended on May 11, 2023, because there had been no changes in disease severity or clinical manifestation and because robust public health efforts, including vaccination campaigns in higher-income nations, contributed to the containment and prevention of the disease. The 2022-23 global mpox outbreak occurred despite ongoing and repeated calls from African researchers for increased attention on medical countermeasures for the disease. Some feel the end of the declaration was premature and could have possibly contributed to even further reductions in public awareness and preparedness, surveillance, funding, and focus on research and development.


Are mpox vaccines available in African countries?

The availability of mpox vaccines in Africa is currently limited, with significant challenges in accessing sufficient doses to control the ongoing outbreaks. Last week, WHO initiated a process to accelerate vaccine access in countries that have not licensed mpox vaccines. This week, the European Commission's Health Emergency Preparedness and Response Authority (HERA) announced it will collaborate with Bavarian Nordic to donate over 215,000 doses of the company’s MVA-BN® vaccine, also known as JYNNEOS in the US, to Africa CDC for distribution. This vaccine is currently the only one approved by both the US FDA and European Medicines Agency (EMA) for mpox. Last week, USAID announced a donation of 50,000 mpox vaccines to DRC, which expects to begin distributing vaccines later this year. While these donations amount to “a drop in the ocean of the 10 million vaccines the Africa CDC says are needed, it shows that this [emergency declaration] process serves as an important alert to the international community,” Dr. Alexandra Phelan, senior scholar at the Johns Hopkins Center for Health Security, said.


Check out this X thread from Dr. Phelan that provides more context for the PHEIC declaration.


What challenges are associated with controlling the mpox outbreak in Africa?

Challenges include limited vaccine availability, inadequate surveillance systems, and challenging logistics in administering the vaccines. Exacerbating the situation is that the disease is disproportionately impacting vulnerable populations, including those at risk of sexual transmission, such as sex workers, their clients, and men who have sex with men, as well as populations in displacement camps. Additionally, clade Ib mpox is not easily detected with current diagnostic tests, making surveillance more difficult, and the antiviral treatment tecovirimat did not reduce the duration of mpox lesions among children and adults with clade I mpox in DRC, according to research supported by the US NIH.


What other actions are being taken to address the outbreak?

WHO has developed a regional response plan that requires at least US$15 million; the agency has released an initial US$1.5 million from its Contingency Fund for Emergencies. WHO plans to release temporary recommendations in the coming days, and the agency extended for one year its Standing Recommendations for mpox. The Permanent Representatives Committee (PRC) of the African Union (AU) on August 2 made emergency approval of US$10.4 million from existing COVID funds for the Africa CDC to support ongoing efforts and mobilize more resources across the continent. Additionally, national governments and international organizations are working to enhance surveillance, obtain vaccines and improve their distribution, and provide support to affected regions. The US HHS outlined its response to the clade I outbreak in DRC and other African countries in a statement released on August 14.


ECDC, PAHO issue risk assessments for Oropouche virus after first-ever imported cases to Europe, deaths in Brazil

The European Centre for Disease Prevention and Control (ECDC) on August 9 issued an advisory for travelers regarding Oropouche virus, following 19 imported cases in Europe associated with travel to Cuba and Brazil. The imported cases represent the first time the virus has been detected in Europe. Oropouche virus, which is transmitted by midges and mosquitoes and sometimes referred to as “sloth virus,” is currently causing outbreaks in parts of South America, Central America, and the Caribbean, with more than 8,000 cases reported since January 2024.


The ECDC alert follows a risk assessment issued by the Pan American Health Organization (PAHO) on August 3, which said the overall regional risk for the virus is high, with a moderate level of confidence. The assessment noted a recent increase and expansion of cases in newly recorded areas, outside of historically endemic regions, the first-ever reported deaths associated with Oropouche infection, and possible fetal deaths and newborn microcephaly cases following infection of pregnant people, which are still under investigation. Additionally, Florida has reported at least 11 imported cases of Oropouche among people who recently travelled to Cuba.


US CDC urges healthcare providers to be alert for cases of highly transmissible parvovirus B19, particularly among those at higher risk of severe disease

The US CDC this week issued an alert for healthcare providers about a significant increase in parvovirus B19 infections, particularly in children aged 5-9 years. The highly contagious seasonal respiratory virus—also called “fifth disease” and sometimes referred to as “slapped cheek disease” because of the rosy cheek rash it can cause—typically causes mild symptoms such as fever, rash, and joint pain, but can lead to serious complications in pregnant people, individuals with weakened immune systems, or those with blood disorders such as sickle cell disease. The proportion of recent infections, indicated by IgM antibodies, which overall fell below 3% during 2022-24, has increased across all age groups, with children aged 5-9 years showing the most substantial increase, from 15% to 40%.


The CDC advises healthcare providers to be aware of the increased activity and to have increased suspicion for parvovirus B19 among people with symptoms, particularly individuals at higher risk of severe outcomes. For the public, CDC recommends learning about parvovirus B19 symptoms, following general respiratory precautions to prevent spread, including good hand hygiene, and improving indoor air quality. The health advisory comes after the European Centre for Disease Prevention and Control (ECDC) reported higher than expected parvovirus cases in 14 European countries during the first quarter of 2024.

MORE HEADLINES

Q&A, opinion piece examine pandemic agreement negotiations, ideas for benefits sharing

Johns Hopkins Bloomberg School of Public Health: Why We’re Still Waiting for a Pandemic Treaty (adapted from an interview with Center for Health Security Senior Scholar Dr. Alexandra Phelan)

Think Global Health: Using Game Theory to Advance the Pandemic Agreement (opinion)

Foreign Affairs: The World Is Not Ready for the Next Pandemic (opinion)


Opinion pieces, commentaries discuss mpox outbreak in Africa, need for concerted collaboration to end threat

The Telegraph: Africa’s worsening mpox outbreak can no longer be ignored – here’s what needs to be done

MedPage Today: Mpox is Becoming More Deadly. We Need Global Action Now to Prevent Another Pandemic.

STAT: Controlling obesity is a noble goal. Controlling mpox is a far more urgent one

Chatham House: The global response to the mpox outbreak in Africa will show if lessons from COVID-19 have been learned

New York Times: Wealthy Nations Must Prioritize the Global Fight Against Mpox


US CDC updates risk assessment of H5N1, slightly increasing risk outbreak could cause pandemic

STAT: CDC slightly increases risk bird flu could cause a pandemic in latest assessment (see IRAT findings)

CIDRAP: CDC pandemic review of US H5N1 virus on par with earlier assessments from same clade

See also: USA Today: Before a bird flu pandemic, feds prep millions of vaccines. Just in case.


US officials expand testing for bird flu in beef from dairy cattle; testing of additional dairy products show no viable H5 but inconclusive whether aging inactivates virus in raw milk  

Axios: Feds to expand bird flu testing in slaughterhouses

Iowa Capital Dispatch: USDA to take ‘additional step’ in testing beef from former dairy cattle for bird flu

STAT Morning Rounds: Is raw milk cheese safe to consume, given the ongoing outbreak of H5N1 bird flu in dairy cows?

CIDRAP: Federal testing on more retail dairy products finds no live H5N1 virus


Media outlets examine US federal agencies’ responses to H5N1 outbreak in cattle

Reuters: US undercounts bird flu in cattle as farmers shun testing

FERN/New Republic: The agency we need to check bird flu lacks the power to do it

See also: The Hill: 100 million dead birds later, avian flu persists. Blame our policies. (opinion)


Colorado reports 6 cases of H5 bird flu in domestic cats, 2 listed as indoor-only pets with no direct exposure to virus

CPR News: Bird flu cases now detected in domestic cats in Colorado

Food Safety News: Several domestic cats in Colorado have tested positive for bird flu

See also: CPR News: As Colorado’s bird flu outbreak continues, HHS Secretary Xavier Becerra urges Coloradans to be prepared


Australia, India on alert for H5N1 avian flu; France detects virus on farm for first time since January

The Guardian: Ecologists warn deadly H5N1 bird flu could arrive in Australia via Antarctica as preparations ramp up

The Guardian: ‘When, not if’: H5N1 bird flu outbreak could reach Australia this spring, experts warn

Gavi VaccinesWork: Sitting ducks: how likely is a bird flu pandemic in India?

The Poultry Site: France reports avian influenza on farm for first time since January


At least 27 US states reporting ‘very high’ SARS-CoV-2 levels in wastewater as new variants drive summer wave in cases

Vox: Why does it feel like everyone is getting Covid?

ABC News: More than half of US states reporting 'very high' COVID activity levels: CDC

Newsweek: COVID Map Update: Majority of US States Now Have 'Very High' Levels

NPR: New variants contribute to COVID surge. What's the latest guidance?


“We’re going to have to continue to live with COVID. It’s one more thing people have to deal with. It’s another reason your kids might miss school, or you might miss work or another thing to think about when planning gatherings. We’re stuck with it.” – Center for Health Security Senior Scholar Dr. Caitlin Rivers speaking to NPR


Updated COVID vaccines due out this fall will target KP.2, JN.1 variants; some in US may face challenges accessing no-cost vaccines as access program ends

New York Times: Should You Get Another Covid Shot Now?

New York Times: This Program Provided More Than a Million Free Covid Shots. Now It’s Ending.

See also: CIDRAP: Study: COVID vaccines saved 1.6 million lives in Europe


US death rates fell last year for all age groups compared with 2022; COVID-19 drops from 4th to 10th leading cause of death

The Hill: COVID-19 dropped to 10th leading cause of death last year: CDC

AP: COVID-19 falls to No. 10 cause of death in US


Estimated 400M people worldwide have had long COVID, with annual economic impact of about US$1T, review article states

Nature Medicine: Long COVID science, research and policy

New York Times: About 400 Million People Worldwide Have Had Long Covid, Researchers Say

Fortune: Long COVID is a $1 trillion problem with no cure. Experts plead for governments to wake up

See also: CIDRAP: New studies estimate long-COVID rates, identify risk factors


Routine lab tests unreliable in diagnosing long COVID, NIH-backed study shows

Axios: Lab tests couldn't help diagnose long COVID: study

NBC News: NIH study to pinpoint long Covid diagnosis comes up short

ABC News: Routine blood tests are not reliable for diagnosing long COVID, study finds


US state COVID vaccine mandates for healthcare workers associated with increased uptake, study shows

JAMA Network Open: State COVID-19 Vaccine Mandates and Uptake Among Health Care Workers in the US

JAMA Network Open: Vaccine Mandates for Health Care Workers—An Effective Policy Tool for Past and Future Pandemics

MedPage Today: Did COVID Vax Mandates for Health Workers Increase Uptake?


US CDC Vaccines for Children Program has prevented more than 1.1 million deaths, resulted in directs savings of US$540B since 1994

USA Today: How routine vaccines will prevent 1.1 million deaths, save $2.7 trillion

CNN: Childhood vaccinations will have prevented more than 500 million illnesses and 1 million deaths in US since 1994, CDC report says

New York Times: Childhood Vaccines Aren’t Just Saving Lives. They’re Saving Money.

CIDRAP: Vaccines for Children program marks 30 years of kids' immunization success, yet gaps remain


Ticks in US can transmit at least 20 diseases; Lyme disease diagnoses among Medicare patients 7 times higher than public health surveillance data show

Your Local Epidemiologist: Bite-sized Threats of Ticks

CIDRAP: Medicare data estimate Lyme disease rate 7 times higher than surveillance shows


With measles cases up in US this year, federal health officials urge child vaccination before school year starts

CBS News: Measles cases are triple what they were last year in the U.S. Doctors say vaccines can help.

MedPage Today: Why Measles Is 'Coming in Hot' in 2024

Gates Foundation: What to know about recent measles outbreaks worldwide

See also: CIDRAP: Measles vaccine failure linked to very low transmission rates


Pfizer RSV vaccine well-tolerated among immunocompromised adults, with single dose eliciting strong neutralizing response

CIDRAP: Pfizer reports promising findings for RSV vaccine in at-risk younger adults

Reuters: Pfizer's RSV vaccine shows benefit in immuno-compromised adults in study

See also: MMWR: Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024


Focus on animal health, nature-based solutions critical to improve health, prevent pandemics

The New Yorker: The Veterinarians Preventing the Next Pandemic

The Lancet: Nature-based solutions are essential for climate and health action (commentary)

See also: MedPage Today: Are People Spreading Mpox to Their Pets? (more information from the US CDC)


US healthcare workers calling for more education on climate and health, White House conference hears; US HHS, healthcare industry not doing enough to address emissions, opinion says

MedPage Today: Clinicians Need More Education on Climate-Related Health Issues, Expert Says

STAT: HHS says it is working to stop the climate crisis. But it’s really just climate washing (opinion)

See also: New York Times: How Close Are the Planet’s Climate Tipping Points?


466M children live in areas with at least twice as many extremely hot days compared to 6 decades ago, UNICEF analysis warns

AP: Extreme heat increasingly endangers children in West and Central Africa, UNICEF says

Health Policy Watch: Half a Billion Children’s Health at Risk from Extreme Heat – As Days of Exposure Double, UNICEF Warns

See also: Reuters: More than 47,000 people died in Europe last year due to heat, report says

FROM THE CENTER

New episode of Center for Health Security’s podcast, BWC Global Forum, discusses AI and drug discovery


The Johns Hopkins Center for Health Security’s podcast, The BWC Global Forum: Biotech, Biosecurity & Beyond, recently released episode #14 on AI and drug discovery. Guest Dr. Kelly Chibale, founder and director of the University of Cape Town Holistic Drug Discovery and Development Centre (H3D), discusses how he and his team are adapting AI tools for lower-capacity computing systems, particularly in lower-resource settings. AI typically requires advanced computing infrastructure and tremendous power and other resources to utilize. Dr. Chibale’s team is applying these lower-capacity AI systems to support African-centric drug discovery, utilizing data from local populations and tailoring products to their specific genotypic and phenotypic characteristics.


Listen now wherever you access podcasts.

Editor: Alyson Browett, MPH

Contributing Editor: Prarthana Vasudevan, MS, MSPH, DrPH (c)

Give Today
Click to Subscribe
 
X  Youtube  Linkedin